LQDA - United Therapeutics: Exciting Company With A Big Problem
2024-06-02 10:27:52 ET
Summary
- United Therapeutics is a biotech company with a strong earnings growth and a lead product that contributes over 50% of its revenues.
- The company has been successful in preventing a competitive product from entering the market, but its options to continue this fight are running out.
- The article will discuss the investment merits of United Therapeutics and the status of the competitive challenge it is facing.
This is my inaugural take on United Therapeutics ( UTHR ), a commercial stage biotech with long growing earnings and a nice product portfolio. Its lead product generates more than 50% of its revenues. It has been fighting tooth and nail to prevent competitive products from entering the market....
United Therapeutics: Exciting Company With A Big Problem